Personal profile
Expertises
Molecular Pathology with focus on mutational analysis in cancers and Human papillomavirus derived cancers; Expertise on clinical diagnostic technologies for cervical screening purposes; Clinical technologies for detection of HPV in non-gynaecology cancers; Detection and characterization of treatment defining mutations in tumors; Biobanks; Guidelines; Private-public collaborations
Main research areas
Human papilomavirus in cancers; Colo-rectal cancer characterization with respect to tumor mutations; Epigenetic changes in cancers
Current research
Human papilomavirus in cancers; Colo-rectal cancer characterization with respect to tumor mutations; Epigenetic changes in cancers
Potential conflicts of interest
Jesper Bonde has within the last five years served as a paid advisor to Roche Molecular Systems, and Genomica SAU, and has received honoraria or travel costs compensation from Hologic, Roche, QIAGEN, Genomica, and BD Diagnostics, European Cytology Association, International Cytology Association, International Papillomavirus Society, and American Society of Clinical Virology for lectures. He is principal investigator on studies funded by BD Diagnostics.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Evaluation of targeted next-generation sequencing for detection of HPV genotypes and sublineages in cervical liquid-based cytology SurePath samples from the Danish screening program
Andersen, K., Bonde, J., Waldstrøm, M., Jakobsen, M. V., Lamy, P., Pedersen, H., Bønløkke, S., Stougaard, M. & Steiniche, T., 1 Jan 2026, In: International Journal of Cancer. 158, 1, p. 193-201 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Health care policy trial of primary human papillomavirus-based cervical screening in Denmark: Comparison of three triage algorithms
Schroll, J. B., Bonde, J., Lynge, E., Waldstrøm, M., Viborg, P. H., Frandsen, A., Andersen, R. H., Nielsen, S. M., Kristensen, B. K., Schledermann, D., Andersen, B. & National Danish Cervical Cancer Screening Steering Committee, 7 Feb 2026, (E-pub ahead of print) In: International Journal of Cancer.Research output: Contribution to journal › Journal article › Research › peer-review
-
Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2+ from childhood vaccinated women: The Trial23 cohort study
Nonboe, M. H., Napolitano, G., Schroll, J. B., Andersen, B., Christiansen, S., Frandsen, A. P., Pedersen, H., Lynge, E., Bonde, J. & Høgdall, E., 15 Feb 2026, In: Vaccine. 73, 128142.Research output: Contribution to journal › Journal article › Research › peer-review
-
Clinical Validation of the Venus HPV Full-Genotyping Assay for Cervical Cancer Screening in the VALGENT-4 Framework
Xu, L., Ma, C., Cuschieri, K., Bonde, J. & Arbyn, M., Aug 2025, In: Journal of Medical Virology. 97, 8, p. e70527 e70527.Research output: Contribution to journal › Journal article › Research › peer-review
-
Lack of consensus in calculation of interval cancer rates for cervical cancer screening
Fitzpatrick, P., Mooney, T., Williams, Y., Mohan, C. M., Bonde, J., Gao, J., Nowakowski, A., Haelens, A., Ivanus, U., Pankakoski, M., Karapetyan, T. & Russell, N. E., Sept 2025, In: Acta Obstetricia et Gynecologica Scandinavica. 104, 9, p. 1705-1711 7 p.Research output: Contribution to journal › Journal article › Research › peer-review